Drug Trial Radar · NCT04501978
ACTIV-3: Therapeutics for Inpatients With COVID-19
Last checked: Nov 20, 2026Latest source record: Aug 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,753
Actual
Start
Aug 4, 2020
Primary completion
Apr 6, 2022
Study completion Jul 14, 2023
Sponsor
- Sponsor type
- NIH
- Collaborators
- International Network for Strategic Initiatives in Global HIV Trials (INSIGHT); University of Copenhagen; Medical Research Council; Kirby Institute; Washington D.C. Veterans Affairs Medical Center; Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; National Heart, Lung, and Blood Institute (NHLBI); US Department of Veterans Affairs; Prevention and Early Treatment of Acute Lung Injury; Cardiothoracic Surgical Trials Network; Eli Lilly and Company; Vir Biotechnology, Inc.; GlaxoSmithKline; Brii Biosciences Limited; AstraZeneca; Molecular Partners AG; Pfizer; University of Minnesota
- First posted
- Aug 6, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.
Conditions
- Covid19
Interventions
LY3819253Biological
Participants are no longer being randomized to this intervention.
PlaceboDrug
Commercially available 0.9% sodium chloride solution. Administered by IV infusion
RemdesivirBiological
Provided to all study participants as SOC unless contraindicated for an individual patient.
VIR-7831Biological
Participants are no longer being randomized to this intervention.
BRII-196/BRII-198Biological
Participants are no longer being randomized to this intervention.
AZD7442Biological
Participants are no longer being randomized to this intervention.
MP0420Drug
Participants are no longer being randomized to this intervention.
PF-07304814Drug
250 mg per day for 5 days. Administered as a constant rate intravenous infusion. Suspended: Participants are not currently being randomized to this intervention.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from randomization to sustained recoveryTime frame: Up to Day 90
Locations
135 sites in 10 countries. Site status is shown where the registry gives one.
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Tucson, Arizona
Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave.
Tucson, Arizona
Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304
Chula Vista, California
Community Regional Medical Center (Site 203-005), 2823 Fresno Street
Fresno, California
Velocity San Diego (Site 080-035), 5565 Grossmont Center Drive, Building 2, Suite 1
La Mesa, California
VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street
Loma Linda, California
VA Long Beach Healthcare System (Site 074-026), 5901 East 7th Street (09/151-M2)
Long Beach, California
Keck Hospital of USC (Site 301-020), 1500 San Pablo Street
Los Angeles, California
Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd.
Los Angeles, California
Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza
Los Angeles, California
Sacramento VA Medical Center (Site 074-023), 10535 Hospital Way
Mather, California
Hoag Memorial Hospital Presbyterian (Site 080-026), One Hoag Drive
Newport Beach, California
Palo Alto VAMC (Site 074-005), 3801 Miranda Avenue
Palo Alto, California
UC Davis Health (Site 203-004), 2315 Stockton Blvd.
Sacramento, California
VA San Diego Healthcare System (Site 074-016), 3350 La Jolla Village Drive
San Diego, California
UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St.
San Francisco, California
San Francisco VAMC (Site 074-002), 4150 Clement St.
San Francisco, California
UCSF Medical Center (Site 203-001), Moffitt-Long Hospital, 505 Parnassus Ave.
San Francisco, California
Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr.
Stanford, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, CDCRC Building
Torrance, California
University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue
Aurora, Colorado
Denver Public Health (Site 017-004), 660 Bannock St., MC2600 (Infectious Disease Clinic)
Denver, Colorado
National Jewish Health / St. Joseph Hospital (Site 204-003), 1400 Jackson Street
Denver, Colorado
West Haven VA Medical Center (Site 025-007), 950 Campbell Avenue
West Haven, Connecticut
MedStar Georgetown University Hospital (Site 067-001), 3800 Reservoir Road NW
Washington D.C., District of Columbia
MedStar Health Research Institute (Site 009-021), MedStar Washington Hospital Center, 110 Irving St., NW.
Washington D.C., District of Columbia
Washington DC VA Medical Center (Site 009-004), 50 Irving Street NW
Washington D.C., District of Columbia
Bay Pines VAMC (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104
Bay Pines, Florida
Baycare Health System (Site 301-025), Morton Plant Hospital, 300 Pinellas Street
Clearwater, Florida
North Florida/South Georgia Veterans Health System (Site 074-011), 1601 SW. Archer Road
Gainesville, Florida
Memorial Healthcare System (Site 648-002), Memorial Regional Hospital, 3501 Johnson Street
Hollywood, Florida
Miami VAMC (Site 074-003), 1201 NW 16 Street
Miami, Florida
Hillsborough County Health Department, University of South Florida (Site 032-001)
Tampa, Florida
Emory University (Site 301-008), The Emory Clinic, Bldg. A, Suite 2236, 1365 Clifton Rd., NE
Atlanta, Georgia
Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard
Fort Wayne, Indiana
Cotton O'Neil Clinical Research Center (Site 080-030), Stormont Vail Health, 1500 SW 10th Avenue
Topeka, Kansas
University of Kentucky Hospital (Site 210-004), 1000 South Limestone St.
Lexington, Kentucky
Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway
New Orleans, Louisiana
University of Maryland Medical Center (Site 301-019), 22 South Greene Street
Baltimore, Maryland
Massachusetts General Hospital (Site 202-002), 55 Fruit Street
Boston, Massachusetts
Showing 40 of 135 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.